Drug Profile
Research programme: antibody-drug conjugates - BioMed Valley Discoveries
Alternative Names: BVD CD276 ADC; BVD TEM8 ADCLatest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator BioMed Valley Discoveries
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 31 Aug 2023 Preclinical development is ongoing in USA (BioMed Valley Discoveries pipeline, August 2023)
- 25 Feb 2016 Preclinical trials in Cancer in USA (unspecified route) before February 2016